Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein DDI1 homolog 1 (DDI1) is a ubiquitin-dependent protease and proteasomal shuttle factor that plays a unique role in protein quality control and cellular homeostasis[4][1]. DDI1 contains three major domains: a ubiquitin-like (UBL) domain, a retroviral protease-like (RVP) domain, and often a ubiquitin-associated (UBA) domain, though the latter is absent in mammals[1][3][4]. The RVP domain structurally resembles retroviral proteases but is distinct in its requirement for substrate polyubiquitylation: DDI1 protease activity is only triggered when substrate proteins are tagged with long polyubiquitin chains (>8 ubiquitins)[4]. DDI1 mediates the degradation or processing of polyubiquitinated proteins, working synergistically with the proteasome, and can cleave specific substrates under stress or when proteasomal function is impaired[4]. DDI1 and its mammalian homologs (such as DDI2) also play a role in the regulation of the transcription factor Nrf1, which controls the expression of proteasome subunits and adaptation to proteotoxic stress[4]. There is growing interest in DDI1 as a potential therapeutic target in oncology, infection (notably malaria, as in Plasmodium falciparum), and potential resistance mechanisms to proteasome inhibitors, due to its unique substrate specificity and structural similarity to viral proteases[4][1][5].
Inhibition of retroviral protease-like (RVP) domain (as for nelfinavir)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein DDI1 homolog 1 (DDI1).